SG11201506197TA - Combination vaccine for respiratory syncytial virus and influenza - Google Patents

Combination vaccine for respiratory syncytial virus and influenza

Info

Publication number
SG11201506197TA
SG11201506197TA SG11201506197TA SG11201506197TA SG11201506197TA SG 11201506197T A SG11201506197T A SG 11201506197TA SG 11201506197T A SG11201506197T A SG 11201506197TA SG 11201506197T A SG11201506197T A SG 11201506197TA SG 11201506197T A SG11201506197T A SG 11201506197TA
Authority
SG
Singapore
Prior art keywords
influenza
respiratory syncytial
syncytial virus
combination vaccine
vaccine
Prior art date
Application number
SG11201506197TA
Inventor
Gale E Smith
Greg Glenn
Lou Fries
James F Young
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novavax Inc filed Critical Novavax Inc
Publication of SG11201506197TA publication Critical patent/SG11201506197TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
SG11201506197TA 2013-02-11 2014-02-11 Combination vaccine for respiratory syncytial virus and influenza SG11201506197TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361763309P 2013-02-11 2013-02-11
US201361875327P 2013-09-09 2013-09-09
PCT/US2014/015725 WO2014124423A1 (en) 2013-02-11 2014-02-11 Combination vaccine for respiratory syncytial virus and influenza

Publications (1)

Publication Number Publication Date
SG11201506197TA true SG11201506197TA (en) 2015-09-29

Family

ID=50185053

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201506197TA SG11201506197TA (en) 2013-02-11 2014-02-11 Combination vaccine for respiratory syncytial virus and influenza

Country Status (13)

Country Link
US (1) US20140227309A1 (en)
EP (1) EP2953642A1 (en)
JP (1) JP2016509015A (en)
KR (1) KR20150138184A (en)
CN (1) CN105101992A (en)
AU (1) AU2014214590A1 (en)
BR (1) BR112015019126A2 (en)
CA (1) CA2900489A1 (en)
IL (1) IL240504A0 (en)
MX (1) MX2015010305A (en)
RU (1) RU2015138530A (en)
SG (1) SG11201506197TA (en)
WO (1) WO2014124423A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11446374B2 (en) 2008-12-09 2022-09-20 Novavax, Inc. Modified RSV F proteins and methods of their use
HUE051666T2 (en) 2008-12-09 2021-03-29 Novavax Inc Modified rsv f proteins and methods of their use
US9149521B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9504743B2 (en) 2013-09-25 2016-11-29 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149522B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9017698B2 (en) 2013-09-25 2015-04-28 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
JP6764408B2 (en) 2014-12-19 2020-09-30 オレゴン ヘルス アンド サイエンス ユニバーシティー Synthetic combination of computer-optimized broad-reactive antigens for H1N1 influenza
CN114796474A (en) 2015-09-03 2022-07-29 诺瓦瓦克斯股份有限公司 Vaccine compositions with improved stability and immunogenicity
CN106822887A (en) * 2017-01-26 2017-06-13 中国科学院微生物研究所 A kind of influenza virus tetravalence subunit vaccine and its application
CN107961371B (en) * 2017-04-19 2020-08-11 武汉博沃生物科技有限公司 Seasonal influenza-RSV combined vaccine and preparation method and application thereof
AU2019238171A1 (en) 2018-03-19 2020-09-24 Novavax, Inc. Multivalent influenza nanoparticle vaccines
CN110559434B (en) * 2018-06-05 2022-08-19 普莱柯生物工程股份有限公司 Avian influenza virus-like particle vaccine, and preparation method and application thereof
WO2024089634A1 (en) * 2022-10-27 2024-05-02 Pfizer Inc. Immunogenic compositions against influenza and rsv

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01006214A (en) * 1998-12-17 2004-09-06 Aventis Pasteur Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation.
EP2181121A4 (en) * 2007-03-21 2012-07-11 Id Biomedical Corp Quebec Chimeric antigens
JP2010533737A (en) * 2007-07-19 2010-10-28 ノババックス，インコーポレイテッド Chimeric varicella-zoster virus-virus-like particles
HUE051666T2 (en) * 2008-12-09 2021-03-29 Novavax Inc Modified rsv f proteins and methods of their use

Also Published As

Publication number Publication date
EP2953642A1 (en) 2015-12-16
AU2014214590A1 (en) 2015-08-27
KR20150138184A (en) 2015-12-09
JP2016509015A (en) 2016-03-24
MX2015010305A (en) 2015-11-18
RU2015138530A (en) 2017-03-20
CA2900489A1 (en) 2014-08-14
CN105101992A (en) 2015-11-25
US20140227309A1 (en) 2014-08-14
IL240504A0 (en) 2015-09-24
WO2014124423A1 (en) 2014-08-14
BR112015019126A2 (en) 2017-08-22

Similar Documents

Publication Publication Date Title
IL258831A (en) Respiratory syncytial virus vaccine
IL261204A (en) Influenza virus vaccines and uses thereof
IL262123A (en) Influenza virus vaccines and uses thereof
IL240504A0 (en) Combination vaccine for respiratory syncytial virus and influenza
SG11201510746WA (en) Respiratory syncytial virus (rsv) vaccine
HK1214962A1 (en) Influenza virus immunogenic compositions and uses thereof
HK1223110A1 (en) Influenza virus vaccines and uses thereof
ZA201700165B (en) Influenza virus vaccines and uses thereof
HK1199211A1 (en) Influenza virus vaccines and uses thereof
IL240936B (en) Influenza virus reassortment and methods for preparation thereof
PT2806891T (en) Parainfluenza virus 5 based vaccines
SG11201610443WA (en) Influenza virus vaccines and uses thereof
HK1219482A1 (en) Quinazoline based respiratory syncytial virus inhibitors
HK1220656A1 (en) Attenuated influenza viruses and vaccines
IL244354A0 (en) Influenza vaccine and therapy
EP3022298A4 (en) Attenuated influenza vaccines and uses thereof
HK1223644A1 (en) Semi-live respiratory syncytial virus vaccine
EP3240568A4 (en) Recombinant influenza virus vaccines for influenza and respiratory syncytial virus
HK1223643A1 (en) Semi-live respiratory syncytial virus vaccine
HK1201283A1 (en) Influenza c virus and vaccine
LT3383428T (en) Respiratory syncytial virus vaccine
IL249705A0 (en) Influenza virus vaccines and uses thereof
IL249704A0 (en) Influenza virus vaccines and uses thereof